Literature DB >> 10337414

Neurointensive care of aneurysmal SAH.

L Persson1, P Enblad.   

Abstract

This paper briefly reviews some basic principles of neurosurgical intensive care of patients with aneurysmal subarachnoid hemorrhage. The importance of early identification of secondary insults are underlined. Special attention is paid to the newly introduced method for neurochemical monitoring by means of intracerebral microdialysis. It is concluded that a well functioning neurointensive care unit constitutes an important organisational frame for the detection, prevention and treatment of secondary insults, after aneurysmal subarachnoidal hemorrhage and that improved results can be expected by applying a modern neurointensive care strategy also for patients with aneurysmal subarachnoid hemorrhage.

Entities:  

Mesh:

Year:  1999        PMID: 10337414     DOI: 10.1007/978-3-7091-6377-1_6

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  4 in total

1.  Clinical outcome after endovascular coil embolization in elderly patients with subarachnoid hemorrhage.

Authors:  M Johansson; O Norbäck; G Gál; K G Cesarini; M Tovi; S Solander; C F Contant; E Ronne-Engström; P Enblad
Journal:  Neuroradiology       Date:  2004-04-17       Impact factor: 2.804

2.  Daily systemic energy expenditure in the acute phase of aneurysmal subarachnoid hemorrhage.

Authors:  Christoffer Nyberg; Elisabeth Ronne Engström; Lars Hillered; Torbjörn Karlsson
Journal:  Ups J Med Sci       Date:  2019-11       Impact factor: 2.384

3.  Outcome from spontaneous subarachnoid haemorrhage--results from 2007-2011 and comparison with our previous series.

Authors:  Elisabeth Ronne-Engström; Ljubisa Borota; Raj Kothimbakam; Niklas Marklund; Anders Lewén; Per Enblad
Journal:  Ups J Med Sci       Date:  2013-10-23       Impact factor: 2.384

Review 4.  Glucose and the injured brain-monitored in the neurointensive care unit.

Authors:  Elham Rostami
Journal:  Front Neurol       Date:  2014-06-06       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.